Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Gene Therapy for β-Hemoglobinopathies: From Discovery to Clinical Trials

Viruses(2023)10.3390/v15030713Source: DataRank Database

Gene Therapy for β-Hemoglobinopathies: From Discovery to Clinical Trials is a research paper published in Viruses (2023). On theSindex it has a DataRank of 0. It has been cited 25 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access25 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 4.21)OA: goldTopics (74)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Paul G. Ayoub ORCID,Kevyn L. Hart ORCID,Donald B. Kohn ORCID,Eva Segura

Live enrichment

PubMed:36992422 PMC:PMC10054523 OpenAlex:https://openalex.org/W4323863245

NHLBI NIH HHS

Grant: R01 HL161291

NIDDK NIH HHS

Grant: TL1 DK132768

National Institutes of Health

Grant: 1R01HL161291-01

Developing gene therapy strategies to treat alpha thalassemia

UCLA Eli & Edythe Broad Center

FWCI

4.21

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/1999-4915/15/3/713/pdf?version=1678701283

publisherhttps://www.mdpi.com/1999-4915/15/3/713/pdf?version=1678701283

publisherhttps://www.mdpi.com/1999-4915/15/3/713/pdf

journalhttps://doi.org/10.3390/v15030713

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36992422

Fields of Study

Hemoglobinopathies and Related DisordersCRISPR and Genetic EngineeringPrenatal Screening and Diagnostics03 medical and health sciences0303 health sciencesHumansbeta-ThalassemiaHematopoietic Stem Cell TransplantationGenetic VectorsHemoglobinopathiesAnemia, Sickle CellGenetic Therapybeta-Globins

MeSH Terms

Anemia, Sickle CellGenetic VectorsHemoglobinopathiesHumansGenetic Therapybeta-ThalassemiaHematopoietic Stem Cell Transplantationbeta-Globins

Keywords

Genetic enhancementMedicineThalassemiaDiseaseClinical trialHematopoietic stem cell transplantationGlobinProgenitor cellBioinformaticsStem cellGeneBiologyGeneticsInternal medicineHemoglobinGene therapyβ-thalassemiaClinical TrialsSickle Cell DiseaseLentiviral VectorsΒ-hemoglobinopathiesΒ-globin GenesAutologous Hematopoietic Stem-cell Transplantbeta-hemoglobinopathiesClinical Trials and Supportive ActivitiesGenetic VectorsReviewAnemia, Sickle Cellbeta-GlobinsRegenerative MedicineMicrobiologybeta-thalassemiaRare DiseasesStem Cell Research - Nonembryonic - HumanClinical ResearchHumansTransplantation5.2 Cellular and gene therapiesCooley's AnemiaAnemiaHematologyGenetic TherapyBiological SciencesStem Cell ResearchQR1-502Sickle CellHemoglobinopathiesbeta-globin genesOrphan DrugBloodGood Health and Well BeingDevelopment of treatments and therapeutic interventionsBiotechnology

Sustainable Development Goals

SDG 0: Good health and well-being